[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: COVIMABS & SOC: 1) Details :- A total of 32 subjects in phase 1 study in the four cohorts (6 ZRC COVIMABS plus SOC + 2 SOC in each cohort) 2)Dose :-300mg;600mg;1200mg;2400mg3)Route:-Intravenous4)Phase II:-The treatment arms; cohorts; sample size; and treatment allocation scheme for phase 2 will be finalized after review of phase I data.Control Intervention1: NA: NA", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: COVIMABS & SOC: 1) Details :- A total of 32 subjects in phase 1 study in the four cohorts (6 ZRC COVIMABS plus SOC + 2 SOC in each cohort) 2)Dose :-300mg;600mg;1200mg;2400mg3)Route:-Intravenous4)Phase II:-The treatment arms; cohorts; sample size; and treatment allocation scheme for phase 2 will be finalized after review of phase I data.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: NA: NA", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "300mg,600mg,1200mg,2400mg", "treatment_id": 1895, "treatment_name": "Zrc-3308", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: COVIMABS & SOC: 1) Details :- A total of 32 subjects in phase 1 study in the four cohorts (6 ZRC COVIMABS plus SOC + 2 SOC in each cohort) 2)Dose :-300mg;600mg;1200mg;2400mg3)Route:-Intravenous4)Phase II:-The treatment arms; cohorts; sample size; and treatment allocation scheme for phase 2 will be finalized after review of phase I data.Control Intervention1: NA: NA", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: COVIMABS & SOC: 1) Details :- A total of 32 subjects in phase 1 study in the four cohorts (6 ZRC COVIMABS plus SOC + 2 SOC in each cohort) 2)Dose :-300mg;600mg;1200mg;2400mg3)Route:-Intravenous4)Phase II:-The treatment arms; cohorts; sample size; and treatment allocation scheme for phase 2 will be finalized after review of phase I data.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: NA: NA", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]